USP EP BP Oogun ite 148408-66-6 Docetaxel trihydrate fun Itoju ti Akàn Tumor
Ọjaoruko | Docetaxel Trihydrate |
Awọn itumọ ọrọ sisọ | (αR, βS) -β- [[(1,1-dimethylethoxy) carbonyl] amino] -a-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS) -12b -(acetyloxy) -12- (benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13 ,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4] benz [1,2-b] oxet-9-yl ester,hydrate (1:3) |
CAS No. | 148408-66-6 |
Ifarahan | Funfun si pa-funfun kristali lulú |
Fọọmu Molecular | C43H53NO14.3(H2O) |
Òṣuwọn Molikula | 861.94 |
Ohun elo | Pharma ite tabi iwadi idi |
Iṣakojọpọ | Gẹgẹbi ibeere rẹ |
Ibi ipamọ | Fipamọ ni wiwọ, awọn apoti sooro ina ni aye tutu |
NKANKAN | Awọn ajohunše | Esi |
Awọn ohun kikọ | A: Funfun si pa-funfun okuta lulú | Ni ibamu |
B: Solubility: Insoluble ninu omi, tiotuka ni ethanol ati acetone | Ni ibamu | |
Ni patoRotation | ﹣38.5°~﹣41.5° | ﹣40° |
Idanimọ | 1.IR: Kanna lati ṣayẹwo ayẹwo | Ni ibamu |
2.UV: λmax232nm | Ni ibamu | |
| Ni ibamu | |
| Ni ibamu | |
Awọn idoti | Lapapọ awọn aimọ: NMT 1.0% | 0.29% |
Awọn aimọ A: NMT 0.5% | 0.0551% | |
Awọn aimọ B: NMT 0.3% | 0.0470% | |
Awọn aimọ C: NMT 0.3% | 0.0535% | |
Eyikeyi aimọ ẹyọkan: NMT 0.1% | 0.0702% | |
Omi | 5.0% - 7.0% | 6.15% |
Aloku lori iginisonu | NMT 0.1% w/w | 0.03% |
Irin eru | NMT 20ppm | Ni ibamu |
Ayẹwo | 97.5% ~ 102.0% | 99.7% |
Ipari | O pade EP7.5. |
Ile-iṣẹ Alaye
√ Iriri kikun ti Layer iṣakoso ni ile-iṣẹ ati awọn ọmọlẹyin awọn onimọ-ẹrọ oye; √ Didara nigbagbogbo jẹ akiyesi oke wa, Eto QC to muna; √ 11 ọdun ti o ni iriri ẹgbẹ tita ọja okeere; √ Lab R&D olominira; √ Awọn idanileko GMP igba pipẹ ti a fowo si; √ Awọn orisun ọlọrọ ti ọpọlọpọ awọn ile-iṣelọpọ laišišẹ fun iṣẹ akanṣe; √ Ẹgbẹ iṣẹ ṣiṣe ti o ga julọ pẹlu ọna deede.Kọ ifiranṣẹ rẹ nibi ki o si fi si wa